FDA Educational Materials Outline New Dietary Ingredient Notification Process for Supplements - Quality Assurance & Food Safety
FDA released educational materials clarifying the New Dietary Ingredient (NDI) notification process, emphasizing that supplements containing new ingredients must submit an NDI notification at least 75 days before marketing. This affects all supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Ongoing; for new products, at least 75 days before marketing. For existing products, immediate review and submission if not already done.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA clarified the NDI notification process, reinforcing that any dietary supplement containing a new dietary ingredient (not present in the food supply as an article used for food in a chemically unaltered form) must submit an NDI notification to FDA at least 75 days before introducing the product into interstate commerce.
Who it affects
Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers
What you must do
Review all supplement products for new dietary ingredients and submit NDI notifications for any that qualify, or ensure existing notifications are compliant.
Deadline
Ongoing; for new products, at least 75 days before marketing. For existing products, immediate review and submission if not already done.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- Warning Letters | FDA
- FDA Advisory No.2026-0735 || Public Health Warning on the Presence of Sildenafil Citrate in TURBO Maca and Clavo Huasca Dietary Supplement Capsules for Men with Lot Number 24TRB1102 - Food and Drug Administration - fda.gov.ph
- FDA Advisory No.2026-0162-A || Lifting the Advisory on the Registered Food Product LUXE SKIN BEAUTY TALKS L’ANNA Premium Oral Sunblock + Stem Cell Dietary Supplement “Public Health Warning Against the Purchase and Consumption of the Unregis - fda.gov.ph
- The Dietary Supplement Industry in the Time of Trump: Potential Opportunities and Pitfalls - Food and Drug Law Institute (FDLI)
- 60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - GlobeNewswire